$28.5 6.3%
Price vs. AI Score (Last 150 days)
Data gathered: December 11

Data Bits

Data Bits Value / Change Benchmark
Job Posts N/A N/A
Sentiment N/A N/A
Webpage traffic N/A N/A
Employee Rating N/A N/A
Linkedin Employees N/A N/A
Patents N/A N/A
4chan Mentions N/A N/A
Stocktwits Mentions N/A N/A
Stocktwits Subscribers N/A N/A
Twitter Followers N/A N/A
Instagram Followers N/A N/A
News Mentions N/A N/A
Reddit Mentions N/A N/A
Business outlook N/A N/A

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

In the news

About Intellia Therapeutics

Intellia Therapeutics is a clinical-stage biotechnology company focused on developing novel, potentially curative therapeutics leveraging CRISPR-based technologies.

Intellia Therapeutics
Price $28.5
Target Price Sign up
Market Cap $2.6B
Dividend Yield 0
Industry Biotechnology

Similar companies

Company Price AI Score

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda
Q3 '2313M29M-16M-122M-131M
Q2 '2316M31M-14M-124M-132M
Q1 '2320M27M-7.1M-103M-112M
Q4 '2222M24M-1.6M-113M-105M
Q3 '2221M22M-1.6M-113M-96M

Insider Transactions

Bhanji Muna filed to sell 11,996 shares at $23.9.
November 2 '23
Bhanji Muna filed to sell 12,261 shares at $42.3.
August 2 '23
Bhanji Muna filed to sell 12,526 shares at $39.3.
July 10 '23
Clark Eliana filed to sell 45,146 shares at $40.5.
July 6 '23
Clark Eliana filed to sell 45,146 shares at $45.
June 22 '23
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2023 AltIndex. All rights reserved.